A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in Wisconsin (Hep-Net)

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Hepatitis C

Treatments

Behavioral: Hep-Net Intervention
Behavioral: Usual Care

Study type

Interventional

Funder types

Other

Identifiers

NCT02474043
2013-1360

Details and patient eligibility

About

The goal of this study is to evaluate the effectiveness of a brief, computerized behavioral intervention for promoting screening for hepatitis C and reducing risky behavior for people who inject drugs (PWID).

Full description

People who inject drugs (PWID) are at high risk for hepatitis C virus (HCV) infection if they share contaminated injection equipment with others. Many are infected but are unaware of it, making it likely they will transmit the virus to others if they share contaminated injecting equipment. Problems related to hepatitis C can be avoided if people know their status by getting tested and referred to treatment. In this study, the investigators will recruit eligible PWID in several cities in Wisconsin using a social networks strategy, in which clients who receive services at a syringe exchange program are asked to refer peers who also inject drugs to participate in the study. All participants will undergo a baseline computerized risk assessment that elicits information about hepatitis C status, previous testing, transmission risk behaviors, and overdose risk. Participants will then be randomly-assigned to receive either standard risk reduction counseling from a prevention specialist, or computerized tailored risk reduction messages that are specific to their reported risk behaviors, attitudes and beliefs. A follow-up assessment will be completed after 3 months to evaluate changes in behavioral risk and intention to undergo HCV screening. A database will be searched to determine which participants returned for HCV screening within 12 months of enrollment, and of those, which ones tested positive for HCV.

Enrollment

235 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 or over
  • English-speaking
  • Reports injection of illicit drugs in the past month

Exclusion criteria

  • Unable to provide informed consent due to cognitive impairment
  • Unwilling to provide personal locator information and consent to be contacted for follow-up after 3 months.
  • Currently known to be pregnant

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

235 participants in 2 patient groups

Usual care
Active Comparator group
Description:
Standard health education and prevention counseling by trained staff
Treatment:
Behavioral: Usual Care
Hep-Net Intervention
Experimental group
Description:
Computerized tailored behavioral intervention
Treatment:
Behavioral: Usual Care
Behavioral: Hep-Net Intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems